Article
Preclinical safety profile of sildenafil.
International journal of impotence research - 1 Dec 2004
Abbott D, Comby P, Charuel C, Graepel P, Hanton G, Leblanc B, Lodola A, Longeart L, Paulus G, Peters C, Stadler J
Abstract excerpt
Sildenafil citrate, marketed as Viagra, for the treatment of erectile dysfunction, has a proven record of safety in humans as predicted by the results of extensive pharmacological and toxicological testing in animals and in vitro, and confirmed by pharmacokinetic exposure data. The aim of this paper is to review succinctly the main findings resulting from these experiments. Daily doses of sildenafil, within and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
